1 enrolling by invitation, 1 recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
Follow Okami Medical, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Okami Medical ALPHA Registry LOBO Vascular Occlusion System - Arterial Bleed, Pulmonary Arteriovenous Malformation | Enrolling by invitation | Okami Medical, Inc. | 500 | 2026-03-31 | 2026-07-21 | |
| Efficacy & Safety of LOBO™ Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations PAVM Embolization, PAVM Embolization with a LOBO™ device - Pulmonary Arteriovenous Malformations | Not applicable | Recruiting | University of North Carolina, Chapel Hill | 30 | 2024-12-17 | 2026-02-17 |
Hemorrhage (1) · Pulmonary Arteriovenous Fistulas (1)
United States (2)
Nima Kokabi, MD (1)